cp wire

CP Wire Articles

Microbiome Report

4D Pharma Commences Ph 1/II Asthma Trial
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announces an update on its... read more

Sat, 07/20/19 - 07:20 pm
Axial Biotherapeutics Doses First Patient in Ph Ib-IIa Trial of AB-2004 for Treatment of Autism Related GI Dysfunction and Behavioral Symptoms

Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and neurodevelopmental disorders, announced on 7/16/19... read more

Thu, 07/18/19 - 12:55 pm
Vida Ventures Makes Progress Towards $600 Million Fund Goal

Life science focused Vida Ventures is advancing on its goal of raising $600 million for its second VC fund. According to a recent... read more

Wed, 07/17/19 - 10:24 am
Xynomic Pharma Files For $65 Million Offering

Clinical stage biopharma, Xynomic Pharma, filed the paperwork for a new $65 Million offering. The company is developing small molecule treatments for several different cancer types. It trades on... read more

Thu, 07/11/19 - 09:44 am
SIFI announces expansion on the French market with the acquisition of DACUDOSES® and NOVOPTINE®
SIFI, the Italian leader in ophthalmology, is pleased to announce the acquisition of Dacudoses® and ... read more
Mon, 07/8/19 - 10:40 am

Pages